CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors

Jianghua Wang(Michael E. DeBakey VA Medical Center), Baiyong Li(Zhongshan Hospital)
Cancer Immunology Immunotherapy
January 27, 2024
10.1007/s00262-023-03604-2
Cited by 19

Related Papers

Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis
|Oncotarget|2015|84
Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-κB Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer
|PLoS ONE|2013|43